Skip to main content

Articles

Page 7 of 16

  1. Germline mutations in APC and AXIN2 are both associated with colon neoplasia as well as anomalous dental development. We tested the hypothesis that congenitally missing teeth may occur more commonly in individual...

    Authors: Noralane M Lindor, Aung Ko Win, Steven Gallinger, Darshana Daftary, Stephen N Thibodeau, Renato Silva and Ariadne Letra
    Citation: Hereditary Cancer in Clinical Practice 2014 12:7
  2. The object of this study was the investigation of the risk of occurrence of malignant neoplasms in 508 patients with Dupuytren’s disease (DD) and in 2157 of their 1st degree relatives. In the first stage of th...

    Authors: Andrzej Żyluk, Katarzyna Paszkowska-Szczur, Satish Gupta, Rodney J Scott, Jan Lubiński and Tadeusz Dębniak
    Citation: Hereditary Cancer in Clinical Practice 2014 12:6
  3. The association of neurofibromatosis type I with invasive male breast cancer is a rare clinical entity with only one case in literature reported in 1953. Women with NF1 are at risk of developing breast cancer ...

    Authors: Kuntegowdanahalli Chinnagiriyappa Lakshmaiah, Anil N Kumar, Samit Purohit, Belathur Kalegowda Viveka, Kamalakannan Rahul Rajan, Mohammed Abdul Lateef Zameer, Prabhu Namitha, Monika Lamba Saini, Hatem A Azim Jr and Kamal S Saini
    Citation: Hereditary Cancer in Clinical Practice 2014 12:5
  4. Patients with familial adenomatous polyposis (FAP) are known to have an increased risk for gastric adenomas. The clinical features of gastric adenomas in FAP have not been well characterized, and there is a la...

    Authors: Saowanee Ngamruengphong, Lisa A Boardman, Russell I Heigh, Murli Krishna, Maegan E Roberts and Douglas L Riegert-Johnson
    Citation: Hereditary Cancer in Clinical Practice 2014 12:4
  5. Testicular germ cell tumor (TGCT) is the most common malignancy in young men. Familial clustering, epidemiologic evidence of increased risk with family or personal history, and the association of TGCT with gen...

    Authors: Christine M Mueller, Larissa A Korde, Mary L McMaster, June A Peters, Gennady Bratslavsky, Rissah J Watkins, Alex Ling, Christian P Kratz, Eric A Wulfsberg, Philip S Rosenberg and Mark H Greene
    Citation: Hereditary Cancer in Clinical Practice 2014 12:3
  6. Folate plays a pivotal role in DNA synthesis, repair, methylation and homocysteine (Hcy) metabolism. Therefore, alterations in the folate-mediated one-carbon metabolism may lead to abnormal methylation prolife...

    Authors: Xiayu Wu, Tianning Zou, Neng Cao, Juan Ni, Weijiang Xu, Tao Zhou and Xu Wang
    Citation: Hereditary Cancer in Clinical Practice 2014 12:2
  7. Patients with Lynch Syndrome, the most common hereditary colorectal cancer syndrome, benefit from genetic education and family counseling regarding diagnostic testing and cancer surveillance/prevention recomme...

    Authors: Sarah A Bannon, Maureen Mork, Eduardo Vilar, Susan K Peterson, Karen Lu, Patrick M Lynch, Miguel A Rodriguez-Bigas and YiQian Nancy You
    Citation: Hereditary Cancer in Clinical Practice 2014 12:1
  8. Familial adenomatous polyposis (FAP) is usually characterised by the appearance of hundreds-to-thousands of adenomas throughout the colon and rectum and if left untreated the condition will develop into CRC wi...

    Authors: Bente A Talseth-Palmer, Juul T Wijnen, Eva K Andreassen, Daniel Barker, Shantie Jagmohan-Changur, Carli M Tops, Cliff Meldrum, Allan Spigelman, Frederik J Hes, Tom Van Wezel, Hans FA Vasen and Rodney J Scott
    Citation: Hereditary Cancer in Clinical Practice 2013 11:20
  9. Although case–control studies have evaluated the role of variant inflammatory-related loci in prostate cancer, their impact is virtually unknown among men of African descent. To address this, we evaluated the ...

    Authors: Dominique Z Jones, Camille Ragin, Nayla C Kidd, Rafael E Flores-Obando, Maria Jackson, Norma McFarlane-Anderson, Marshall Tulloch-Reid, Kevin S Kimbro and LaCreis R Kidd
    Citation: Hereditary Cancer in Clinical Practice 2013 11:19
  10. Genetic counselling and testing for Lynch syndrome have recently been introduced in several South American countries, though yet not available in the public health care system.

    Authors: Mev Dominguez-Valentin, Mef Nilbert, Patrik Wernhoff, Francisco López-Köstner, Carlos Vaccaro, Carlos Sarroca, Edenir Ines Palmero, Alejandro Giraldo, Patricia Ashton-Prolla, Karin Alvarez, Alejandra Ferro, Florencia Neffa, Junea Caris, Dirce M Carraro and Benedito M Rossi
    Citation: Hereditary Cancer in Clinical Practice 2013 11:18
  11. The effectiveness of a genetics-based public health screening programs depend on the successful recruitment of subjects who qualify for intensified screening by virtue of a positive genetic test. Herein we com...

    Authors: Anna Galor, Cezary Cybulski, Jan Lubiński, Steven A Narod and Jacek Gronwald
    Citation: Hereditary Cancer in Clinical Practice 2013 11:17
  12. Familial adenomatous polyposis (FAP) is a well-defined autosomal dominant predisposition to the development of polyposis in the colon and rectum at unusually early ages. The first symptoms of FAP are diarrhea ...

    Authors: Andrzej Plawski, Tomasz Banasiewicz, Pawel Borun, Lukasz Kubaszewski, Piotr Krokowicz, Marzena Skrzypczak-Zielinska and Jan Lubinski
    Citation: Hereditary Cancer in Clinical Practice 2013 11:15
  13. Little is known about the experience of young women who become aware of their parent’s BRCA1 or BRCA2 (BRCA) mutation status as adolescents or young adults. There is also currently a gap in the literature pert...

    Authors: Lynn Macrae, Alicia Navarro de Souza, Carmen G Loiselle and Nora Wong
    Citation: Hereditary Cancer in Clinical Practice 2013 11:14
  14. Lifetime risk of thyroid cancer associated with FAP has been reported as 1-2%. The mean age at diagnosis of thyroid carcinoma in FAP has been reported at 28 years. The aims of this paper are to better understa...

    Authors: Seth Septer, Voytek Slowik, Ryan Morgan, Hongying Dai and Thomas Attard
    Citation: Hereditary Cancer in Clinical Practice 2013 11:13
  15. Several susceptibility genes differentially impact on the lifetime risk for breast cancer. Technological advances over the past years have enabled the detection of genetic risk factors through high-throughput ...

    Authors: Natalia Bogdanova, Sonja Helbig and Thilo Dörk
    Citation: Hereditary Cancer in Clinical Practice 2013 11:12
  16. Von Hippel-Lindau disease (VHL disease) is a hereditary cancer predisposition syndrome caused by mutations of the von Hippel-Lindau tumor suppressor gene. The gene product, pVHL, regulates the level of protein...

    Authors: Katarzyna Labno-Kirszniok, Teresa Nieszporek, Andrzej Wiecek, Grzegorz Helbig and Jan Lubinski
    Citation: Hereditary Cancer in Clinical Practice 2013 11:11
  17. Preimplantation genetic diagnosis (PGD) remains nowadays a valid alternative for couples at high-risk of having a child with a genetic disease and for women older than 37–40 years with the high risk of chromos...

    Authors: Danuta Michalska, Kinga Jaguszewska, Joanna Liss, Kamila Kitowska, Agata Mirecka and Krzysztof Łukaszuk
    Citation: Hereditary Cancer in Clinical Practice 2013 11:10
  18. Lynch syndrome (clinically referred to as HNPCC – Hereditary Non-Polyposis Colorectal Cancer) is a frequent, autosomal, dominantly-inherited cancer predisposition syndrome caused by various germline alteration...

    Authors: Katarzyna Tutlewska, Jan Lubinski and Grzegorz Kurzawski
    Citation: Hereditary Cancer in Clinical Practice 2013 11:9
  19. Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS) and proteus syndrome are disorders known as PTEN hamartoma tumour syndrome (PHTS), that can show remarkable clinical overlap and are all caused by...

    Authors: Lorella Paparo, Giovanni Battista Rossi, Paolo Delrio, Daniela Rega, Francesca Duraturo, Raffaella Liccardo, Mario Debellis, Paola Izzo and Marina De Rosa
    Citation: Hereditary Cancer in Clinical Practice 2013 11:8
  20. Most individuals who learn about hereditary cancer manage well, but identification of subgroups who find this knowledge burdening would allow psychosocial intervention. The objective of the study was to assess...

    Authors: Helle Vendel Petersen, Steen Ladelund, Christina Carlsson and Mef Nilbert
    Citation: Hereditary Cancer in Clinical Practice 2013 11:7
  21. Follow-up studies of psoriasis patients indicate an increased risk in the occurrence of malignancies at different sites of origin. Population stratification and/or complicated interpretation of evidence on the...

    Authors: Romuald Maleszka, Katarzyna Paszkowska-Szczur, Ewa Soczawa, Magdalena Boer, Monika Różewicka-Czabańska, Joanna Wiśniewska, Aneta Mirecka, Lidia Krysztoforska, Zygmunt Adamski, Jan Lubinski and Tadeusz Dębniak
    Citation: Hereditary Cancer in Clinical Practice 2013 11:6
  22. PIK3CA is the most frequently mutated oncogene in human cancers. PIK3CA is phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha. It controls cell growth, proliferation, motility, survival, d...

    Authors: Sidra German, Hafiz Muhammad Aslam, Shafaq Saleem, Aisha Raees, Tooba Anum, Arsalan Ahmad Alvi and Abdul Haseeb
    Citation: Hereditary Cancer in Clinical Practice 2013 11:5
  23. Hamartomas are tumour-like malformations, consisting of disorganized normal tissues, typical of the site of tumour manifestation. Familial manifestation of hamartomatous polyps can be noted in juvenile polypos...

    Authors: Zoran Stojcev, Pawel Borun, Jacek Hermann, Piotr Krokowicz, Wojciech Cichy, Lukasz Kubaszewski, Tomasz Banasiewicz and Andrzej Plawski
    Citation: Hereditary Cancer in Clinical Practice 2013 11:4
  24. Cancer is a shared family experience that might provide an opportunity for lifestyle change among at-risk family members. The purpose of this study was to assess receptivity and preferences for cancer risk red...

    Authors: Lisa A Howell, Pamela S Sinicrope, Tabetha A Brockman, Christi A Patten, Paul A Decker, Shawna L Ehlers, Ashley Nadeau, Kari G Rabe, Carmen Radecki Breitkopf and Gloria M Petersen
    Citation: Hereditary Cancer in Clinical Practice 2013 11:3
  25. The history of specific therapy for hereditary tumors dates back to mid 1980s and involves a number of reports demonstrating regression of familial colon polyps upon administration of sulindac. Virtually no cl...

    Authors: Evgeny N Imyanitov and Tomasz Byrski
    Citation: Hereditary Cancer in Clinical Practice 2013 11:2
  26. Family history is among the few established risk factors for testicular germ cell tumor (TGCT). Approximately 1.4% of newly diagnosed TGCT patients report a positive family history of TGCT. Sons and siblings o...

    Authors: Rodrigo Santa Cruz Guindalini, Edite Paulo de Oliveira, Marina Cavalcanto Moroja Silvino, Paulo Marcelo Hoff and Bernardo Garicochea
    Citation: Hereditary Cancer in Clinical Practice 2013 11:1
  27. Worldwide, gastric cancer is one of the most common forms of cancer, with a high morbidity and mortality. Several environmental factors predispose to the development of gastric cancer, such as Helicobacter pylori

    Authors: Ingrid P Vogelaar, Rachel S van der Post, Tanya M Bisseling, J Han JM van Krieken, Marjolijn JL Ligtenberg and Nicoline Hoogerbrugge
    Citation: Hereditary Cancer in Clinical Practice 2012 10:18
  28. Authors: A Kurlapska, P Serrano-Fernández, T Starzyńska, E Małecka-Panas, G A Dąbrowski, T Dębniak, G Kurzawski, J Suchy, W Rogoza-Mateja, R J Scott and J Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A26

    This article is part of a Supplement: Volume 10 Supplement 4

  29. Authors: Katarzyna Kaczmarek, Anna Jakubowska, Grzegorz Sukiennicki, Magdalena Muszyńska, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Tomasz Huzarski, Pablo Serrano-Fernandez, Tomasz Byrski, Jacek Gronwald, Satish Gupta and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A6

    This article is part of a Supplement: Volume 10 Supplement 4

Annual Journal Metrics

  • 2022 Citation Impact
    1.7 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    0.634 - SNIP (Source Normalized Impact per Paper)
    0.526 - SJR (SCImago Journal Rank)

    2023 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    131 days submission to accept (Median)

    2023 Usage 
    394,813 downloads
    196 Altmetric mentions